The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning
Journal of Hematology · 2023-10 · 12 (5) · 201-207
DOI: 10.14740/jh1148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematology, 2023-10. Verfasst von Sorana G Ursu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15224, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology/Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15224, USA.
ORCID-Profile: Sorana G Ursu
Zitieren
APA
Ursu, S. G., Maples, S., Williams, K. J., Patrus, G., Samhouri, Y., Fazal, S., Mewawalla, P., & Sadashiv, S. (2023). The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning. Journal of Hematology, 12(5), 201-207. https://doi.org/10.14740/jh1148
Vancouver
Ursu SG, Maples S, Williams KJ, Patrus G, Samhouri Y, Fazal S, et al. The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning. Journal of Hematology. 2023;12(5):201-207. doi:10.14740/jh1148
BibTeX
@article{Ursu2023,
author = {Ursu, Sorana G and Maples, Samantha and Williams, Kiersten J and Patrus, Gina and Samhouri, Yazan and Fazal, Salman and Mewawalla, Prerna and Sadashiv, Santhosh},
title = {The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning},
journal = {Journal of Hematology},
year = {2023},
volume = {12},
number = {5},
pages = {201--207},
doi = {10.14740/jh1148}
}
EUVIMED